Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists

Area of Science:

• Pharmacology
• Neuroscience
• Medicinal Chemistry

Background:

• Dopamine D4 receptors play crucial roles in neurological functions.
• G protein-coupled receptor (GPCR) signaling bias is a key area in drug discovery.
• Existing ligands like APH199 show biased signaling profiles.

Purpose of the Study:

• To design and synthesize novel dopamine D4 receptor ligands with distinct signaling bias.
• To evaluate the functional profiles, including efficacy, potency, and G protein-coupled receptor kinase 2 (GRK2) dependency.
• To investigate the structural basis of signaling bias using molecular docking.

Main Methods:

• Synthesis of novel D4 receptor ligands based on the APH199 scaffold, modifying the benzyl phenylsemicarbazide moiety.
• Functional assays to assess G-protein versus beta-arrestin signaling, efficacy, potency, and GRK2 dependency.
• Molecular docking studies to explore ligand interactions with the D4 receptor, focusing on ECL2 and EPB.

Main Results:

• Newly synthesized biphenylmethyl urea and biphenyl urea ligands exhibited a wide range of bias factors (1 to >300) and activation levels (15% to >98%).
• Compounds displayed diverse signaling profiles, demonstrating precise tuning of D4 receptor bias.
• Docking studies provided insights into the structural determinants of bias, involving ECL2 and EPB interactions.

Conclusions:

• Precise tuning of dopamine D4 receptor signaling bias is achievable through chemical modification.
• These findings highlight the potential of functionally selective D4 agonists in future drug development.
• Understanding structural elements like ECL2 and EPB is crucial for designing biased ligands.